US Patent Issued to The United States of America, as represented by the Secretary, Department of Health and Human Services on May 19 for "Methods of isolating T cells and T cell receptors having antigenic specificity for a cancer-specific mutation from peripheral blood" (American, Spanish Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,802, issued on May 19, was assigned to The United States of America, as represented by the Secretary, Department of Health and Human Services (Bethesda, Md.).

"Methods of isolating T cells and T cell receptors having antigenic specificity for a cancer-specific mutation from peripheral blood" was invented by Alena Gros (Barcelona, Spain) and Steven A. Rosenberg (Potomac, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are methods of isolating T cells and TCRs having antigenic specificity for a mutated amino acid sequence encoded by a cancer-specific mutation. Also disclosed are related methods of preparing a population of cells, populatio...